Hillary Vanderven

Hillary Vanderven is a Senior Lecturer in Immunology/Infectious Disease at James Cook University, Townsville. She holds a PhD from the University of Melbourne and specializes in immune responses to viral pathogens, particularly influenza. Her research focuses on enhancing vaccine efficacy in high-risk groups and developing antibody-based therapies.

Education:

• B.Sc. in Immunology and Infectious Disease (University of Alberta, 2004–2008)
• M.Sc. in Physiology/Cell Biology (University of Alberta, 2008–2011)
• PhD in Immunology (University of Melbourne, 2014–2018)

Research Interests:

• Antibody-mediated immunity
• Influenza vaccine design
• Host-pathogen interactions
• Novel antibody therapies

Articles Trends: Recent work emphasizes Fc-mediated antibody functions in severe viral infections, miRNA regulation in avian influenza, and TB antibody applications. Key contributions include studies on Flu-IVIG treatment and NK cell responses in HIV.

Awards:

• Qiagen PhD Achievement Award (2017)
• NSERC CGS-M Scholarship (2009)
• International Postgraduate Research Scholarship (2014)

Teaching & Advising: Supervises honors and PhD students in biomedical sciences. Coordinates advanced projects in immunology and biomedicine. Teaches courses like Advanced Immunology and Veterinary Cell Biology.

Labs & Teams: Active in JCU’s Infectious Disease Research Group, collaborating on projects like peptide-MHC antibody therapies and ADCC antibody treatments for influenza B.